Transfected Cell Line for Drug Discovery Aimed at Splicing Correction
TS-000113 — Technology Overview
Researchers at the Research Institute have developed a stably transfected cell line that expresses wild type survival motor neuron gene-2 (SMN2) that can be used as a drug discovery tool aimed at gene splicing correction. SMN2 is a potential therapeutic target for Proximal Spinal…
- College:
- Inventors: Chandler, Dawn; Bebee, Thomas; Gladman, Jordan
- Licensing Officer: Murrah, Kyle